Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Positron Emission Tomography
100%
Polyethylene Terephthalate
53%
Fluorodeoxyglucose F 18
43%
Positron Emission Tomography-Computed Tomography
38%
Neoplasm
37%
Fluorodeoxyglucose
28%
Fluorine-18
28%
Cervical Cancer
26%
Scintigraphy
22%
Diseases
18%
Non Small Cell Lung Cancer
17%
Glucose
15%
Radiation Therapy
15%
Computer Assisted Tomography
14%
Lymph Node
13%
Prostate Cancer
13%
Standardized Uptake Value
13%
Metastatic Carcinoma
13%
Recurrent Disease
13%
Malignant Neoplasm
12%
Pelvis
11%
Tumor
11%
Colorectal Carcinoma
10%
Pulmonary Embolism
10%
Medicare
9%
Overall Survival
8%
Indium 111
8%
Amyloid Protein
8%
Breast Cancer
8%
Radiology
8%
Lymph Node Metastasis
7%
Oncology
7%
Chemoradiotherapy
7%
Carcinoma
7%
Platelet
7%
Cancer
6%
Magnetic Resonance Imaging
6%
Technetium-99
6%
Chemotherapy
6%
Primary Tumor
6%
Iodine 131
6%
Clinical Trial
6%
Diethylstilbestrol
5%
Biological Marker
5%
Diagnostic Performance
5%
Radiopharmaceutical
5%
Biopsy Technique
5%
Liver Metastasis
5%
Progression Free Survival
5%
Cervix
5%
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
80%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
29%
Tumor
26%
Cervical Cancer
22%
18F-fluorodeoxyglucose (18F-FDG)
19%
Fluorodeoxyglucose
16%
Standardized Uptake Value
13%
Computed Tomography
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
12%
SUVmax
11%
Non-small Cell Lung Cancer (NSCLC)
9%
Radiopharmaceuticals
9%
Cervical Carcinoma
8%
Fluoro
8%
Amyloid Positron Emission Tomography
8%
Overall Survival
7%
Positron
7%
Oncologic
7%
American College of Radiology
7%
National Oncologic PET Registry
7%
Fluorodeoxyglucose Uptake
7%
Breast Cancer
7%
Technetium-99m
6%
Positive Predictive Value
6%
95% Confidence Interval
6%
Pulmonary Embolism
6%
Liver
6%
F-18 Fluorodeoxyglucose
6%
FDG Uptake
5%
Infarction
5%
Primary Tumor
5%
Radiological Imaging
5%
Radiation Therapy
5%
Scintigraphy
5%
Diagnostic Performance
5%
Image Network
5%
Platelets
5%
Tumor Response
5%
Autologous Platelet
5%
Metabolic Tumor Volume
5%